July 2024

33 Articles

Clinical Insights

Sepsis scoring systems: Mindful use in clinical practice

22 May 2024
Author(s): Luigi Mario Castello, Francesco Gavelli

Sepsis is a challenging condition: the high prevalence and the complexity of its clinical presentation lead to high morbidity and mortality. The most updated definition of sepsis and septic shock,... more

Towards precision medicine in COPD: Targeting type 2 cytokines and alarmins

17 May 2024
Author(s): Gilda Varricchi, Remo Poto

Chronic obstructive pulmonary disease (COPD) is a main global epidemic increasing as population age and affecting approximately 10% of subjects over 45 years. COPD is a heterogeneous inflammatory... more

Commentary

Use simple tools to improve complex conditions

17 May 2024
Author(s): Michele Vitacca, Mara Paneroni

"Medicine is both an art and a science; the art of listening, the art of understanding, and the art of predicting." (Hippocrates)

Low-dose colchicine for chronic stable atherosclerosis: Under-appreciated and under-prescribed

17 May 2024
Author(s): Paul M Ridker

In June of 2023, the United States Food and Drug Administration (FDA) approved the use of low dose colchicine as the first anti-inflammatory drug to treat atherosclerotic disease. Specifically, “... more

Artificial intelligence supported ultrasonography: Can it be the solution for early and accurate diagnosis of steatotic liver disease?

24 April 2024
Author(s): Stella Gabeta, Eirini I. Rigopoulou, George N. Dalekos

Last December, a multi-society Delphi consensus reported on the new nomenclature and definitions of fatty liver disease [1]. Accordingly, the previous terms of non-alcoholic fatty liver disease (... more

Corrigendum

Corrigendum to “Systemic diseases associated with a diagnosis of achalasia: A case-control study with the All of Us research program” [European Journal of Internal Medicine 104C (2022) 125–127]

24 May 2024
Author(s): Erik Almazan, Gayane Yenokyan, Kenneth Ng

The authors regret that one of the tables in the above published article. The correct version of the table is below:

Internal Medicine Flashcard

Surfers' myelopathy

20 May 2024
Author(s): Kento Arai, Kosuke Ishizuka, Mori Nakai

A 29-year-old Japanese man presented with bilateral weakness in the legs and low back pain. On the day of admission, the patient had gone surfing for the first time in his life and developed sudden... more

Patchy reversible renal vasoconstriction

20 May 2024
Author(s): Haruka Maruyama, Ken-ei Sada, Takayasu Ohtake

A 24-year-old male patient presented to the emergency department with left-sided back pain and bilateral lower limb myalgia. The previous day, he was involved in a head-on motor-vehicle collision at... more

Internal Medicine Flashcards

An unexpected detour: Acute throat pain and trismus in a fast-food deliveryman

11 April 2024
Author(s): Hidenori Takahashi, Marino Fujisaki, Yuko Hata

A 40-year-old man fast-food deliveryman presented to the emergency department with a severe sore throat and trismus. His-symptoms rapidly escalated over 24 h, impairing his ability to speak, eat, and... more

Letter to the Editor

Kidney function and sarcopenia: A risk assessment. Author's reply

10 May 2024
Author(s): Rafael Moreno-González, Francesc Formiga, Paolo Fabbietti

To the Editor

Resuming antiplatelet therapy in patients with intracranial hemorrhage

26 March 2024
Author(s): Asmaa Ahmed, Mohamed Hamed, Mona Mahmoud, Mamas A Mamas, Ayman Elbadawi, APICH

More than a third of adults who experience primary intracranial hemorrhage (ICH) in high-income countries are prescribed antiplatelet medications due to similar risk factors shared with vascular... more

Polyvalent immunoglobulin use: Issues between good use, economic constraints and shortages over 25 years

25 March 2024
Author(s): Q. Perrier, V. Tuloup, C. Chevallier-Brilloit, P. Bedouch, S. Chanoine, Polyvalent immunoglobulin group

Human normal polyvalent immunoglobulins (HNIg) have been widely used for the treatment of primary and secondary immune deficiencies. They also possess immunomodulatory properties and are employed in... more

A prediction model for differentiating recurrent Kawasaki disease from other febrile illnesses

24 March 2024
Author(s): Penghui Yang, Jing Zhang, Siqi Feng, Qijian Yi

Kawasaki disease (KD) can result in coronary artery aneurysms (CAA), elevating the risk of coronary artery thrombosis in the later stage [1]. Intravenous immunoglobulin within the first 10 days after... more

Long-term compliance of lipoprotein apheresis patients. What is health-related quality of life?

23 March 2024
Author(s): Beatrice Dal Pino, Carmen Corciulo, Andrea Ripoli, Federico Bigazzi, Francesco Sbrana

Clinical research and scientific evidence confirm the role of low-density lipoprotein cholesterol (LDL-C) and lipoprotein (a) [Lp(a)] as a risk factor for atherosclerosis and cardiovascular events.... more

Diagnosis traps for patients with acquired NLRP3 mutation

20 March 2024
Author(s): Margaux Cescato, Laurence Cuisset, Laurent Le Corre, Mathieu P Rodero, Sophie Georgin-Lavialle, on behalf of the F-CAPS study group

Cryopyrinopathies (cryopyrin-associated periodic syndrome, CAPS), also referred to as NLRP3 mutation-associated autoinflammatory diseases (NLRP3-AID), have historically been described as three... more

Antibiotic shortages in Europe: Another question of prices?

16 March 2024
Author(s): L Garattini, B Finazzi, A Mazzone

Pharmaceutical shortages are currently a worldwide issue despite advancement in manufacturing and transport technologies [1]. Surprisingly, shortages still happen in many high-income countries too... more

Changes in the Dynamic Trajectory of Remnant Cholesterol Affect the Occurrence of Nonalcoholic Fatty Liver Disease

14 March 2024
Author(s): Xinlei Miao, Manling Hu, Qianqian Wang, Guimin Tang, Song Leng

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease worldwide, affecting approximately 20–25 % of the global adult population [1]. Epidemiological evidence showed that,... more

Chronic limb-threatening ischemia with no revascularization option: Result from a multidisciplinary care model

11 March 2024
Author(s): Davide Ceccato, Sonia Ragazzo, Francesca Boscaro, Giampiero Avruscio

Lower extremity chronic limb-threatening ischemia (CLTI) is the most advanced form of peripheral arterial disease (PAD). Historically, development of CLTI was associated with 1-year amputation rates... more

Development and validation of a clinical risk score for all-cause mortality in patients with acquired long QT syndrome

11 March 2024
Author(s): Xiaopeng Dong, Shihao Wang, Cheng Chen, Xiaolei Yang, Yunlong Xia

Dear editor,

Kidney function and sarcopenia: A risk assessment

19 January 2024
Author(s): Tomoyuki Kawada

I read with great interest the paper by Moreno-González et al. [1], who investigated the association between sarcopenia and kidney function in older adults, aged ≥75 years. Estimated glomerular... more

Original Article

Identifying COPD patients with poor health status and low exercise tolerance through the five-repetition sit-to-stand test and modified Medical Research Council Dyspnea Score

15 April 2024
Author(s): Roberto Bernabéu-Mora, Silvana Loana Oliveira-Sousa, Francesc Medina-Mirapeix, Mariano Gacto-Sánchez, Group of Investigation SAQ_COPD

Chronic obstructive pulmonary disease (COPD) is a heterogeneous and systemic condition characterized by chronic respiratory symptoms (dyspnea, cough, sputum production) due to abnormalities of the... more

Clinical significance of the anti-Nucleolar Organizer Region 90 antibodies (NOR90) in systemic sclerosis: Analysis of the European Scleroderma Trials and Research (EUSTAR) cohort and a systematic literature review

9 April 2024
Author(s): A Dima, MC Vonk, A Garaiman, BE Kersten, R Becvar, M Tomcik, A-M Hoffmann-Vold, I Castellvi, JL Tandaipan Jaime, M Brzosko, M Milchert, D Krasowska, M Michalska-Jakubus, P Airo, M Matucci-Cerinic, C Bruni, M Iudici, JHW Distler, AM Gheorghiu, H Poormoghim, F Motta, M De Santis, M Parvu, O Distler, C Mihai

The anti-Nucleolar Organizer Region 90 antibodies (NOR90) are rare antinuclear antibodies (ANA) reported in systemic sclerosis (SSc). Especially due to low prevalence, the clinical relevance of NOR90... more

Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysis

27 March 2024
Author(s): Santiago Jiménez-Marrero, Miguel Cainzos-Achirica, David Monterde, Emili Vela, Cristina Enjuanes, Sergi Yun, Alberto Garay, Pedro Moliner, Miriam Corbella, Sílvia Jovells-Vaqué, Lídia Alcoberro, Alexandra Pons-Riverola, Raul Ramos-Polo, Herminio Morillas, Joan Antoni Gómez-Hospital, Josep Comin-Colet

The inhibition of the renin-angiotensin-aldosterone system (RAAS) is a essential aspect of the medical treatment of several chronic cardiovascular, metabolic, and renal conditions. It plays a vital... more

Sex-based differences in the comprehensive geriatric assessment in elderly hospitalized patients with non-valvular atrial fibrillation

27 March 2024
Author(s): Giuseppe Armentaro, Daniele Pastori, Alberto Castagna, Valentino Condoleo, Velia Cassano, Carlo Alberto Pastura, Mattea Francica, Caterina Benincasa, Nicola D'Alterio, Franco Arturi, Giovanni Ruotolo, Angela Sciacqua

Atrial fibrillation (AF) represents the most common supraventricular arrhythmia in elderly [1]. It was estimated that 1 % to 3 % of the world population suffers from AF, with higher prevalence in the... more

The correlation of atherogenic index of plasma with non-obstructive CAD and unfavorable prognosis among patients diagnosed with MINOCA

26 March 2024
Author(s): Fuad A. Abdu, Jiasuer Alifu, Abdul-Quddus Mohammed, Lu Liu, Wen Zhang, Guoqing Yin, Xian Lv, Ayman A. Mohammed, Redhwan M. Mareai, Yawei Xu, Wenliang Che

Myocardial infarction with non-obstructive coronary arteries (MINOCA) is a complex and intriguing phenomenon with diverse underlying pathophysiological mechanisms that challenge conventional... more

Recurrence of hypertriglyceridemia-associated acute pancreatitis: A multicenter, prospective cohort study

26 March 2024
Author(s): Ling Ding, Shuai Li, Longxiang Cao, Lanting Wang, Jing Zhou, Wenjian Mao, Weiqin Li, Yin Zhu, Lu Ke, the Chinese Acute Pancreatitis Clinical Trials Group (CAPCTG)

Hypertriglyceridemia (HTG) is a well-established etiology of acute pancreatitis (AP), accounting for approximately 4.7–14.3 % of all cases globally [1,2]. Recurrent acute pancreatitis (RAP) is one of... more

Visit-to-visit blood pressure variability is associated with intrinsic capacity decline: Results from the MAPT Study

18 March 2024
Author(s): Leonardo Bencivenga, Mathilde Strumia, Yves Rolland, Sophie Guyonnet, Angelo Parini, Philippe Cestac, Sandrine Andrieu, Philipe De Souto Barreto, Laure Rouch, For the MAPT/DSA group

Blood Pressure (BP) values fluctuate over time around average values, as a consequence of the interaction between multiple intrinsic and environmental factors affecting the cardiovascular system [1... more

Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography

14 March 2024
Author(s): Sergio Santoro, Mohamad Khalil, Hala Abdallah, Ilaria Farella, Antonino Noto, Giovanni Marco Dipalo, Piercarlo Villani, Leonilde Bonfrate, Agostino Di Ciaula, Piero Portincasa

Nonalcoholic fatty liver disease (NAFLD) refers to liver steatosis, i.e., over-storage of fat, mainly triglycerides, in the hepatocytes, without other causes for secondary hepatic fat accumulation [1... more

Prognosis of COVID-19 severity using DERGA, a novel machine learning algorithm

8 March 2024
Author(s): Panagiotis G. Asteris, Amir H. Gandomi, Danial J. Armaghani, Styliani Kokoris, Anastasia T. Papandreadi, Anna Roumelioti, Stefanos Papanikolaou, Markos Z. Tsoukalas, Leonidas Triantafyllidis, Evangelos I. Koutras, Abidhan Bardhan, Ahmed Salih Mohammed, Hosein Naderpour, Satish Paudel, Pijush Samui, Ioannis Ntanasis-Stathopoulos, Meletios A. Dimopoulos, Evangelos Terpos

The Coronavirus Disease 2019 (COVID-19) pandemic, caused by the novel coronavirus Severe Acute Respiratory Syndrome-related Coronavirus-2 (SARS-CoV-2), has had a profound impact on healthcare systems... more

A systematic literature review of randomised controlled trials evaluating colchicine for cardiovascular prevention: There is an elephant in the room

2 January 2024
Author(s): Alessia Alunno, Francesco Carubbi, Cecilia Martini, Veronica Moronti, Jessica Santilli, Jan W Schoones, Francesco Maria Mariani, Evy Di Ruscio, Piera Altieri, Claudio Ferri

Gout is a chronic inflammatory disease burdened by a higher CV risk compared to the general population [1] and this excess risk cannot be explained only by the prevalence of traditional risk factors... more

Review Article

Type 1 diabetes-related distress: Current implications in care

11 April 2024
Author(s): Alba Rodríguez-Muñoz, María José Picón-César, Francisco J. Tinahones, José Ignacio Martínez-Montoro

Type 1 diabetes (T1D) is a complex and demanding chronic disease characterized by a severe lack of insulin synthesis which needs to be supplied exogenously [1,2]. In this context, people living with... more

Gender-specific insights into the irritable bowel syndrome pathophysiology. Focus on gut dysbiosis and permeability

10 March 2024
Author(s): Jerlin Stephy JohnBritto, Agostino Di Ciaula, Antonino Noto, Velia Cassano, Angela Sciacqua, Mohamad Khalil, Piero Portincasa, Leonilde Bonfrate

Irritable bowel syndrome (IBS), a chronic functional gastrointestinal disorder, manifests through recurrent episodes of abdominal pain or discomfort, coupled with variations in bowel habits... more

The impact of colchicine on patients with acute and chronic coronary artery disease

17 January 2024
Author(s): Mehdi Madanchi, Mabelle Young, Gregorio Tersalvi, Giacomo Maria Cioffi, Adrian Attinger-Toller, Florim Cuculi, Reto Kurmann, Matthias Bossard

Inflammation is a major contributor in the development and progression of coronary artery disease (CAD). Preclinical studies have demonstrated that inflammatory processes, by means of specific... more

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness